Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY: BSX )

75.75 +0.39 (+0.52%)
Streaming Delayed Price Updated: 3:54 PM EDT, May 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Boston Scientific

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI... 
Via Benzinga
Earnings Scheduled For July 27, 2021
Companies Reporting Before The Bell • Navios Maritime Partners (NYSE:NMM) is projected to report quarterly earnings at $2.93 per share on revenue of $146.03 million.... 
Via Benzinga
Why Boston Scientific's Stock Is Trading Lower Today
Boston Scientific (NYSE:BSX) shares are trading lower af... 
Via Benzinga
Stocks That Hit 52-Week Highs On Friday
On Friday morning, 152 companies hit new 52-week highs. Things to Consider: The largest company by market cap to hit a new 52-week high was ASML Holding (NASDAQ:... 
Via Benzinga
Boston Scientific Earnings Exceed Expectations As Demand Picks Up, Raises FY21 Guidance
Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.1 billion in Q2 of 2021, beating the estimate of $2.9 billion. Sales increased 53.6% Y/Y on a... 
Via Benzinga
Recap: Boston Scientific Q2 Earnings
Shares of Boston Scientific (NYSE:BSX) fell 1.0% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 400.00% year... 
Via Benzinga
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start... 
Via Benzinga
Exposures Product Safety
Unusual Options Activity Insight: Boston Scientific
Boston Scientific (NYSE:BSX) shares experienced unusual options activity on Thursday. The stock price moved up to $43.24 following the option alert. Sentiment: BULLISH Option... 
Via Benzinga
Understanding Boston Scientific's Unusual Options Activity
Shares of Boston Scientific (NYSE:BSX) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved down to $42.7. Sentiment:... 
Via Benzinga
Boston Scientific's Debt Overview
Over the past three months, shares of Boston Scientific (NYSE:BSX) rose by 12.01%. Before we understand the importance of debt, let us look at how much debt Boston... 
Via Benzinga
Better Buy: Medtronic or Boston Scientific?
Which one of these medical device makers is better poised for a breakout year? 
Via The Motley Fool
Exposures COVID-19
Pete Najarian Sees Unusual Options Activity In Boston Scientific And Deutsche Bank
On CNBC's "Fast Money Halftime Report," Pete Najarian spoke about unusually high options activity in Boston Scientific Corporation (NYSE: BSX) and Deutsche Bank AG (... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2021
Upgrades Bernstein upgraded the previous rating for Wipro Ltd (NYSE:WIT) from Underperform to Market Perform. Wipro earned $0.07 in the fourth quarter, compared to $0.05... 
Via Benzinga
Pipelines Are ESG
ESG is in the eye of the beholder. My favorite is Lockheed Martin, a perennial member of the Dow Jones Sustainability Index. If building weapons to blow up people and property can be done in a... 
Via Talk Markets
Topics Stocks
Exposures US Equities
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021
Upgrades For Appian Corp (NASDAQ:APPN), Macquarie upgraded the previous rating of Underperform to Neutral. For the first quarter, Appian had an EPS of $0.06, compared to... 
Via Benzinga
Pete Najarian Sees Unusual Option Activity In Boston Scientific And Las Vegas Sands
On CNBC's "Fast Money Halftime Report," Pete Najarian gave some unusual option activity plays. Najarian sees unusual activity in: Boston Scientific (NYSE: BSX) May $... 
Via Benzinga
Stock Market Rally Navigates Earnings From Apple, Tesla, Google, Facebook, Microsoft, Amazon
The stock market rally navigated earnings from Apple, Tesla and the other "big six" market cap companies. Many breakouts, but not all succeeded. 
Via Investor's Business Daily
Boston Scientific Stock Jumps On Q1 Earnings Beat, Improved Guidance
Boston Scientific Corporation (NYSE: BSX) Q1 sales grew by 5.9% (organically) to $2.75 billion, beating the previous guidance range between negative... 
Via Benzinga
Topics Earnings
Exposures Financial
Boston Scientific Corp (BSX) Q1 2021 Earnings Call Transcript
BSX earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:... 
Via Benzinga
Boston Scientific: Q1 Earnings Insights
Shares of Boston Scientific (NYSE:BSX) moved higher by 2.9% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 32.... 
Via Benzinga
The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc... 
Via Benzinga
Exposures Product Safety
Boston Scientific Earnings Beat, Guidance Raised; BSX Clears Buy Point
Boston Scientific earnings beat views, with the medical products giant also raising full-year EPS guidance. BSX stock rose back into a buy zone. 
Via Investor's Business Daily
Topics Earnings
Exposures Financial
Cramer Gives His Opinion On Snap, Cleveland-Cliffs And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said Snap Inc (NYSE: SNAP) is going to have a great quarter. It has tremendous growth and Cramer is a buyer. Regal... 
Via Benzinga
The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx
Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:... 
Via Benzinga
Exposures Product Safety
'Halftime Report' Final Trades: Apple, Nvidia And More
On CNBC's 'Fast Money Halftime Report,' the investment committee gave their final trades of the day. Sand Hill Global Advisors’ Brenda Vingiello likes Apple Inc... 
Via Benzinga
The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 22) AtriCure, Inc. (NASDAQ:... 
Via Benzinga
Return On Capital Employed Overview: Boston Scientific
Boston Scientific (NYSE:BSX) posted a 124.76% decrease in earnings from Q3. Sales, however, increased by 1.84% over the previous quarter to $2.71 billion. Despite the increase in... 
Via Benzinga
The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 21) Alexion Pharmaceuticals,... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 15, 2021
Upgrades According to JP Morgan, the prior rating for Vipshop Holdings Ltd (NYSE:VIPS) was changed from Neutral to Overweight. In the fourth quarter, Vipshop Holdings... 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.